Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070 for a new active substance on the Centralized Procedure (CP) registration.
Thanks to our extensive track record of over 20 years, at Asphalion we can assist you in selecting the optimal strategy, optimizing costs and enhancing time-to-market, as well as with all other kind of activities and projects.
CASE STUDY ANALYSIS: BUSINESS CASE TRANSPARENCY POLICY 0070 Asphalion
For further information you can contact us at: [email protected]